Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...

Proton beam therapy, a radiation treatment for cancer, may be effective as a treatment for refractory ventricular tachycardia ...

A new study published in Pharmaceuticals found that cannabidiol (CBD) reduced breast cancer cell growth, promoted apoptosis and altered the expression of genes tied to several major cancer pathways.

New intellectual property milestones strengthen HeartLung’s leadership in AI–enabled preventive CT imaging and coronary ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the first quarter ended March 31, 2026.

Advances in hereditary angioedema attack prophylaxis have provided more options for patients than ever before, with multiple ...

Key opportunities in the bevacizumab biosimilars market arise from increasing cancer prevalence, demand for cost-effective ...

Summit Therapeutics recently released its 10-Q report. Summit is a biopharmaceutical company focused on developing and ...

Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.

J. Craig Venter has died at 79. He mapped the first draft of the human genome. The J. Craig Venter Institute announced his ...

Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology ...